We believe that access to safe and affordable healthcare is a human right. Since 1975 we have contributed to improving global health by supplying quality medicines and medical devices to people all over the world.
We are excited to share our new Sustainability Report for the financial year 2024-25. The report details our ongoing commitments under the UN Global Compact’s principles, with a strong focus on our Environmental, Social, and Governance (ESG) priorities, supported by the Sustainable Development Goals.
At Missionpharma, we are committed to running a sustainable business and to actively taking responsibility for the society and the environment in which we operate.
Our history is marked by our ability to deliver healthcare products globally, significantly improving the lives of more than 100 million people annually. We take great pride in this impact. As a company delivering essential healthcare, it is crucial for us to contribute positively to the world around us, and our mission for better health has never felt more relevant.
Proud participant of the UN Global Compact
Missionpharma has been an active participant of the UN Global Compact since 2018, and we commit to the principles of responsible business conduct promoted by the UN Global Compact and supported by the Sustainable Development Goals.
We particularly support SDG 3: Good Health and Well-Being, SDG 8: Decent work and Economic Growth, SDG 13: Climate Action and SDG 17: Partnership for the Goals.
Download our 2024/25 Sustainability report
Read more about our sustainability efforts
Download Missionpharma’s Sustainability report 2024-25.
The year 2025 marks a very special year for Missionpharma as we proudly celebrate our 50th anniversary.
Since 1975, we have been on an incredibly exciting journey, significantly impacting millions of lives worldwide by supplying more than 100 million treatments every year and creating an exceptional workplace for our 170 employees.
The early years
Our story began in 1975 when Poul Ginnerup established Missionpharma in the family home in Storkevang, Allerød. Supported by his wife, Paule Ginnerup, and later their son, Kim Ginnerup, the Ginnerup family successfully built Missionpharma into the leading global pharmaceutical wholesaler we are today.
Much has changed since Poul started selling off-patent pharmaceuticals to missionary clinics in Africa. Today, our team of 170 employees across three continents serves over 100 million people annually with life-saving healthcare supplies.
Ready for the future
As we reflect on our achievements over the past 50 years, we are just as dedicated to providing better access to quality healthcare as we were back then.
We have cultivated a strong global team of dedicated and passionate employees, and we wish to thank everyone for being an important part of our journey. We are more than ever inspired to continue our mission for better health for all.
Stay tuned on LinkedIn for regular updates on our 50 years of impact.
We are thrilled to announce the release of our new brochure for the Interagency Emergency Health Kit (IEHK) 2024. This brochure provides detailed information about the kit, its purpose, and its composition.
The IEHK 2024, designed by the WHO, is intended to serve an outreach population of 10,000 people for up to 3 months. It is primarily meant for use in the early phase of an emergency, providing essential medicines and medical devices urgently needed for life-saving purposes.
Missionpharma keeps stock of IEHK 2024 and can dispatch the kit within 48 hours in case of humanitarian emergencies or disasters.
Download our new brochure here.
Discover more about our range of kits here.
Download IEHK 2024 brochure
In addition to our role as a leading global supplier of healthcare products, Missionpharma is an active partner in consolidation of health projects funded by the Export & Investment Fund of Denmark (EIFO).
Our overall goal is to enhance healthcare infrastructure worldwide and create new opportunities for Danish exports.
In cooperation with EIFO, we have recently implemented a project in Ivory Coast, aiming to significantly improve the maternal health in the country. The project includes construction or refurbishment of 62 primary healthcare clinics across Ivory coast, benefitting millions of women all over the country.
Read much more about Missionpharma’s role as project aggregator here.
EIFO is the national promotional bank and export credit agency of Denmark combined in one financial institution.
We are now offering essential medicines and medical supplies from stock for immediate delivery!
We recognise the critical need to promptly meet our customers’ demands for healthcare products when a crisis hits.
Therefore, we have taken significant steps to offer a wide range of essential medicines and medical supplies directly from stock, and thereby be able to arrange fast transportation from one of our warehouses in India and Denmark.
Learn more about our recent initiative to ensure a prompt response to your healthcare needs here.
Download the updated version of our product catalogue. Our product offerings are continuously updated.
Download brochure.
For nearly five decades, we have impacted people around the world with our products and our services. As one of the world's largest pharmaceutical wholesalers, we work to provide access to safe healthcare for everyone. Every year more than 100 million people worldwide are treated with medicine from Missionpharma.
We fundamentally believe that access to safe and affordable treatment is a human right, why our core focus is to provide quality medicine and medical devices to vulnerable communities all over the world.
We are determined to make a positive impact on the lives of millions of people globally and to prove our purpose of being on a mission for better health.
In 2023 Missionpharma delivered 40,000 cbm of healthcare products to patients worldwide. This corresponds to 1,400 containers per year or almost 4 containers per day.
Hospital ships that transform lives
In 2023 Missionpharma entered into a long-term partnership with the international humanitarian organisation, Mercy Ships. Mercy Ships operates two hospital ships that offer free surgical operations to the poorest people in Africa.
For many people in low-income countries, surgery is simply not an option, either because it doesn’t exist or it is inaccessible. Onboard the two floating hospital ships, Mercy Ships provides safe surgery for free, transforming thousands of lives in every country it visits.
Mercy Ships operates the two large non-governmental hospital ships, the Africa Mercy and the Global Mercy. The ships bring necessary medical care, surgeries and capacity building to Africa and offer in total 12 operating theatres and nearly 300 patient beds.
Missionpharma’s donation to Mercy Ships in financial year 2023/24 corresponds to 39 life-changing operations on board the ships.
Mercy Ships is an international humanitarian organisation, which operates hospital ships that deliver free surgeries and other healthcare services to those with little access to safe medical care.
Missionpharma is a leading supplier of generic pharmaceuticals, medical consumables, hospital equipment and medical kits to public and private institutions, international development organisations and the UN. Every year we supply medicines to treat more than 100 million people worldwide.
We are committed to making an impact. We provide tailored healthcare solutions built on a deep insight and decades of experience. We have offices in Denmark, India, China and Zambia and employ 160 people. Our head office is based in Denmark, where we employ 60 people and from where our overall business activities are managed.
Since 2012, Missionpharma has been part of CFAO Healthcare, the healthcare division of CFAO Group – a major distributor of international brands in Africa. The Group has wholesale operations and local branches all over Africa.
Since 1975 Missionpharma has provided safe and affordable healthcare products to patients all over the world. We all take great pride in doing what we do to contribute to strengthening global healthcare.
Christian Overgaard, CEO, Missionpharma Group
English
Français
